• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom

Insulet fully launches Omnipod 5 with Dexcom G7 in the U.S. along with iPhone app

June 20, 2024 By Sean Whooley

Insulet Omnipod 5 with Dexcom G7

Insulet (Nasdaq:PODD) announced today that it began a full U.S. launch of Omnipod 5 with the Dexcom G7 continuous glucose monitor (CGM). The company also announced a series of launches and updates, including a limited release of the Omnipod 5 App for iPhone. Insulet also made Omnipod 5 available in France and launched the system […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Dexcom, Insulet

Dexcom launches G7 with Apple Watch integration in the U.S.

June 5, 2024 By Sean Whooley

Dexcom G7 CGM Apple Watch direct-to-watch

Dexcom (Nasdaq:DXCM) announced today that its G7 continuous glucose monitor (CGM) now connects directly to the Apple Watch in the U.S. San Diego-based Dexcom first announced the addition of this capability in March. The official launch makes G7 the first and only CGM available with a direct-to-Apple-Watch feature. It offers users the freedom and convenience […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom earns CGM reimbursement in France for type 2 diabetes

June 4, 2024 By Sean Whooley

Dexcom One

Dexcom (Nasdaq:DXCM) announced today that its Dexcom ONE sensor received reimbursement for those with type 2 diabetes in France. The previous-generation Dexcom ONE sensor originally launched in France last fall. At that time, it covered patients two years and older with type 1 and type 2 diabetes undergoing intensive insulin therapy. Now, the company can […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom, Abbott ask for another trial in CGM patent spat

May 29, 2024 By Sean Whooley

Dexcom G7 Abbott FreeStyle Libre 2 CGM

Abbott (NYSE:ABT) and Dexcom (Nasdaq:DXCM) both submitted legal briefs angling for another trial in an ongoing continuous glucose monitor (CGM) patent spat. In March, the U.S. District Court for the District of Delaware found that Dexcom violated a single patent belonging to Abbott and its FreeStyle Libre sensors. However, the court found that Dexcom did […]

Filed Under: Business/Financial News, Diabetes, Featured, Legal News, Patient Monitoring, Technology Tagged With: abbott, Dexcom

Tandem pairs Mobi automated insulin pump with Dexcom G7

May 29, 2024 By Sean Whooley

Tandem Mobi Dexcom G7

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it integrated its Mobi insulin pump with the Dexcom G7 continuous glucose monitor (CGM). Already compatible with the previous-generation G6, Mobi now pairs with Dexcom’s latest-generation CGM. San Diego-based Tandem launched Mobi, the world’s smallest, durable automated insulin delivery (AID) system in the U.S. this year. It received […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Tandem Diabetes Care

Dexcom launches new sensor in the UK

May 20, 2024 By Sean Whooley

Dexcom One+ real-time continuous glucose monitor CGM system

Dexcom (Nasdaq:DXCM) announced today that it launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK. ONE+ uses Dexcom’s established sensor design, with the company incorporating feedback from users and healthcare professionals to build it. The company said this ensured an easy-to-use, highly effective CGM experience for people treating type 1 or type 2 […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom stock slides despite Q1 beats, sales guidance increase

April 25, 2024 By Sean Whooley

Dexcom updated Logo

Dexcom (Nasdaq:DXCM) shares took a hit after hours today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of DXCM dipped about 7% to $128.40 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the […]

Filed Under: Business/Financial News, Diabetes, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Study highlights benefits of automated insulin delivery for children in UK

April 25, 2024 By Sean Whooley

Medtronic MiniMed 780G with Guardian 4 sensor

A study in the UK demonstrated significant improvements in HbA1c for users of automated insulin delivery technologies. This comes on the heels of a UK NHS initiative to provide tens of thousands of children and adults with type 1 diabetes in the country with an artificial pancreas. The study aimed to assess the efficacy of […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: CamDiab, Dexcom, Medtronic, Tandem Diabetes Care, Ypsomed

Non-insulin, basal CGM use exceeds analysts’ expectations, Dexcom and Abbott to benefit

April 23, 2024 By Sean Whooley

Dexcom G7 Abbott FreeStyle Libre 2 CGM

William Blair analyst Margaret Kaczor reported surprise at the increase in users of CGM within the non-insulin and basal insulin populations. Kaczor expects Dexcom and Abbott to benefit from the trend with their next-generation CGM offerings after meetings with both companies’ management. Both companies launched next-gen CGMs in recent years (Dexcom G7 and Abbott FreeStyle […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Dexcom

Dexcom, MD Revolution partner to integrate CGM into remote care platform

April 10, 2024 By Sean Whooley

Dexcom G7 iPhone (1)

MD Revolution today announced a partnership with Dexcom (Nasdaq:DXCM) to integrate CGM into its remote care management platform. Dexcom develops continuous glucose monitoring technology (CGM), including its latest-generation G7. The system pairs with smartphones — and now Apple Watches — to monitor the glucose levels of people with diabetes. MD Revolution’s remote care management platform […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom, MD Revolution

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 17
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS